SCHEMBL6505595

SCHEMBL6505595

NC(=O)CC1(c2ccc(OCc3ccccc3)cc2)CCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.54
LTA4H P09960 1/20 0.49
NR4A1 P22736 1/20 0.49
NR4A2 P43354 1/20 0.49
NR4A3 Q92570 1/20 0.49
MAOB P27338 2/20 0.47
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
PTGS1 P23219 1/20 0.46
SLC6A2 P23975 1/20 0.46
CYP2C19 P33261 1/20 0.46
PTGS2 P35354 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HIF1A Q16665 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
SRD5A2 P31213 1/20 0.46
FFAR1 O14842 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
RORC P51449 1/20 0.46
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6494035 0.97 PARP10 (0.54) PARP10LTA4HNR4A1NR4A2NR4A3
SCHEMBL6209701 0.96 PARP10 (0.52) PARP10LTA4HNR4A1NR4A2NR4A3
SCHEMBL6210983 0.82 DPP4 (0.57) PARP10LTA4HMAOBLMNACYP1A2
SCHEMBL6210261 0.79 DPP4 (0.62) MAOBLMNACYP1A2PTGS1SLC6A2
SCHEMBL4866308 0.78 DPP4 (0.58) MAOBLMNASLC6A2CYP2C19SLC6A3
SCHEMBL6502368 0.78 SLC6A3 (0.60) MAOBLMNACYP1A2PTGS1SLC6A2
SCHEMBL17761324 0.77 POLB (0.52) PARP10SLC6A2SLC6A3
SCHEMBL17761202 0.77 DPP4 (0.56) MAOBLMNASLC6A2SLC6A3MAOA
SCHEMBL6210960 0.76 BCHE (0.47) PARP10LTA4HNR4A1NR4A2NR4A3
SCHEMBL6208549 0.76 SLC6A4 (0.61) LMNASLC6A2CYP2C19SLC6A3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234096-A1 Tetrahydroisoquinoline derivatives BAYER HEALTHCARE AG (DE) 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234096-A1 Tetrahydroisoquinoline derivatives PPARD, PPARG, PPARA PARP10 1217/4885LTA4H 1239/4885NR4A1 103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.